Survey of Symptoms After a COVID Vaccination in Employees

Completed

• Conditions: Symptoms Recoding SARS-CoV-2 After Vaccination

• Registration Number: NCT06035926
• Lead Sponsor: Medical University of Graz

Brief Summary

Background:

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus type 2) has had us firmly in its grip for more than two years. In January 2021, the quality and risk management unit of the LKH (Landeskrankenhaus) -Univ. Klinikum Graz commissioned to carry out vaccinations for employees and subsequently for high-risk patients.

In the vaccination line, which was open for 85 days in 2021/22, the vaccines from Astra Zeneca, Biontech-Pfizer and Moderna were vaccinated. There were hardly any complications. The primary immunization, booster vaccination and booster vaccination were carried out.

Despite the small number of incidents in the sense of an immediate reaction, there were numerous sick leave.

Methods:

For this reason, in the course of the booster vaccination, starting from October 2021 to January 2022, every vaccinated person was asked to fill out a questionnaire. Participation was voluntary and was supported by the works councils of the Medical University and the LKH-University clinic Graz approved. The survey served to retrospectively record how many employees developed symptoms in response to the respective vaccination.

With this approach it will be possible to subject the responses to an in-depth statistical analysis in order to obtain a data-based contribution to the side effects of vaccines categorized with different vaccination schemes.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-01
• Primary Completion: 2023-07-31
• Study Completion: 2023-07-31
• Study First Submitted: 2023-08-28
• Status Verified: 2023-09
• Study First Submitted QC: 2023-09-06
• Last Update Submitted: 2023-09-06
• Study First Posted: 2023-09-13
• Last Update Posted: 2023-09-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1093

Inclusion Criteria

• Employees with appropriate indication (>4 months after the second vaccination) according to the recommendations of the national vaccination committee.
• Signed vaccination information sheet.

Exclusion Criteria

• no booster vaccination.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Occurrence of symptoms after the respective vaccination	10 Minutes	Occurence of symptoms, assessed by a questionnaire

Trial Locations

Locations (1)

Medical University of Graz; 🇦🇹 Graz, Styria, Austria